Which closed-end funds own Charles River Laboratories International Inc?
12 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $63.9M. Security type: common equity. Country: United States. CUSIP 159864107 · ISIN US1598641074 · ticker CRL.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| GLO Clough Global Opportunities Fund | Multi-Asset | 1.93% | $5.8M | 24,800 sh | $298M | 12.9% discount | Jul 31, 2026 |
| GLQ Clough Global Equity Fund | Global Equity | 1.93% | $3.5M | 15,254 sh | $184M | 13.5% discount | Jul 31, 2026 |
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 1.28% | $13.8M | 60,883 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| THW abrdn World Healthcare Fund | Healthcare | 1.00% | $6.9M | 30,525 sh | $689M | 4.3% discount | Jun 30, 2026 |
| HQH abrdn Healthcare Investors | Healthcare | 0.98% | $13.3M | 58,698 sh | $1.4B | 7.5% discount | Jun 30, 2026 |
| THQ abrdn Healthcare Opportunities Fund | Healthcare | 0.96% | $10.1M | 44,454 sh | $1.1B | 7.7% discount | Jun 30, 2026 |
| TY Tri-Continental Corp | U.S. Equity | 0.42% | $8.8M | 38,659 sh | $2.1B | NAV unavailable | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.20% | $1.1M | 4,936 sh | $573M | 3.7% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.15% | $340K | 1,500 sh | $228M | NAV unavailable | Jun 30, 2026 |
| GUG Guggenheim Active Allocation Fund | U.S. Equity | 0.03% | $178K | 985 sh | $631M | 14.1% discount | May 29, 2026 |
| GGZ Gabelli Global Small & Mid Cap Value Trust | Global Equity | 0.03% | $45.4K | 200 sh | $165M | 11.2% discount | Jun 30, 2026 |
| GOF Guggenheim Strategic Opportunities Fund | Multi-Asset | 0.00% | $19.5K | 108 sh | $2.8B | 12.9% discount | May 29, 2026 |
12 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: CHARLES RIVER LABORATORIES INTERNATIONAL INC; Charles River Laboratories Int.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Charles River Laboratori | debt security | 4 |
| Charles River Laboratori | debt security | 4 |
| Charles River Laboratori | debt security | 2 |
| Charles River Re Ltd | debt security | 1 |
Issuer-level search for “CRL” → · Compare two funds’ portfolios →